Novo Nordisk Shares Fall After 13% Sales Warning Amid Obesity Drug Price War
Novo Nordisk stock drops after warning of a 13% sales decline as U.S. price cuts and rising competition from Eli Lilly intensify the obesity drug price war. Shares of Novo Nordisk A/S fell sharply after the company warned of a potential 13% drop in sales, triggering investor concerns about an escalating price war in the … Read more